Immunolight, LLC Receives 200th Worldwide Patent

Immunolight, LLC, a clinical stage biopharmaceutical firm leading the way in advancing technologies to transform cancer treatment, announced today it has been granted its 200th worldwide and 75th US patent in a wide-ranging patent portfolio.